Reuter VE - Search Results

1

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.

Feldman DR, Ged Y, Lee CH, Knezevic A, Molina AM, Chen YB, Chaim J, Coskey DT, Murray S, Tickoo SK, Reuter VE, Patil S, Xiao H, Aghalar J, Apollo AJ, Carlo MI, Motzer RJ, Voss MH. Feldman DR, et al. Among authors: reuter ve. Cancer. 2020 Dec 15;126(24):5247-5255. doi: 10.1002/cncr.33148. Epub 2020 Sep 25. Cancer. 2020. PMID: 32975815 Free PMC article. Clinical Trial.

2

Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors.

Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RS. Rodriguez E, et al. Cancer Res. 1992 Apr 15;52(8):2285-91. Cancer Res. 1992. PMID: 1313741

3

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.

Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ. Wood DP Jr, et al. Cancer. 1992 Nov 1;70(9):2354-7. doi: 10.1002/1097-0142(19921101)70:9<2354::aid-cncr2820700924>3.0.co;2-u. Cancer. 1992. PMID: 1382832

4

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression.

Motzer RJ, Nanus DM, O'Moore P, Scher HI, Bajorin DF, Reuter V, Tong WP, Iversen J, Louison C, Albino AP, et al. Motzer RJ, et al. Cancer Res. 1992 Oct 15;52(20):5775-9. Cancer Res. 1992. PMID: 1394202 Clinical Trial.

5

t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma.

Rodriguez E, Sreekantaiah C, Reuter VE, Motzer RJ, Chaganti RS. Rodriguez E, et al. Among authors: reuter ve. Cancer Genet Cytogenet. 1992 Dec;64(2):107-10. doi: 10.1016/0165-4608(92)90338-9. Cancer Genet Cytogenet. 1992. PMID: 1486558

6

Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.

Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC. Presti JC Jr, et al. Among authors: reuter ve. Cancer Res. 1991 Mar 1;51(5):1544-52. Cancer Res. 1991. PMID: 1671759

7

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: reuter ve. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

8

The malignant nature of papillary and cystic neoplasm of the pancreas.

Sclafani LM, Reuter VE, Coit DG, Brennan MF. Sclafani LM, et al. Among authors: reuter ve. Cancer. 1991 Jul 1;68(1):153-8. doi: 10.1002/1097-0142(19910701)68:1<153::aid-cncr2820680128>3.0.co;2-n. Cancer. 1991. PMID: 2049737 Review.

9

Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors.

Ladanyi M, Samaniego F, Reuter VE, Motzer RJ, Jhanwar SC, Bosl GJ, Chaganti RS. Ladanyi M, et al. Among authors: reuter ve. J Natl Cancer Inst. 1990 Feb 7;82(3):221-7. doi: 10.1093/jnci/82.3.221. J Natl Cancer Inst. 1990. PMID: 2153216

10

Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma.

Cordon-Cardo C, Reuter VE, Finstad CL, Sheinfeld J, Lloyd KO, Fair WR, Melamed MR. Cordon-Cardo C, et al. Among authors: reuter ve. Cancer Res. 1989 Jan 1;49(1):212-8. Cancer Res. 1989. PMID: 2461798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters